PROVINGO
LIVE

Serial Number

90282008

Owner

PROVEPHARM LIFE SOLUTIONS

Attorney

Kaitlyn Garvin

Filing Date

Oct 27, 2020

Add to watchlist:

No watchlists yet
View on USPTO

PROVINGO Trademark

Serial Number: 90282008 • Registration: 6460125

PROVINGO is a trademark filed by PROVEPHARM LIFE SOLUTIONS on October 27, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

PROVEPHARM LIFE SOLUTIONS (19 trademarks)

22, RUE MARC DONADILLE
MARSEILLE 13013 , FR

Entity Type: 33

Trademark Details

Filing Date

October 27, 2020

Registration Date

August 24, 2021

Published for Opposition

June 8, 2021

Goods & Services

Pharmaceutical preparations in the nature of indigo carmine solutions for marking tissue by injection in surgery and internal medicine, for marking tissue of the digestive system by oral, anal or injectable administration, for oral and topical antiseptic treatment, for marking and functional verification of gynecological and urological systems by instillation, injection or local application; Chemical preparations in the nature of indigo carmine for medical use for marking tissue by injection in surgery and internal medicine, for marking tissue of the digestive system by oral, anal or injectable administration, for oral and topical antiseptic treatment, for marking and functional verification of gynecological and urological systems by instillation, injection or local application; Chemical preparations in the nature of indigo carmine solutions for medical use for marking tissue by injection in surgery and internal medicine, for marking tissue of the digestive system by oral, anal or injectable administration, for oral and topical antiseptic treatment, for marking and functional verification of gynecological and urological systems by instillation, injection or local application; indigo carmine solutions for use as a marker during gastro-intestinal endoscopy; indigo carmine solutions used as a contrast solution for medical imaging procedures; indigo carmine solutions for medical diagnostic purposes for viewing and marking tissue; indigo carmine solutions used as an aid in visualization of topographic irregularities and in delineation of polypoid or flat lesions, including adenomas; indigo carmine solutions used for polyps or lesions resection medicines for tissue staining; indigo carmine solutions for use as a marker during visceral surgery; indigo carmine solutions for the detection of amniotic fluid leaks; indigo carmine solutions for use as a marker during cystoscopy and ureteral catheterization; indigo carmine solutions for use as a marker during vessel delineation and tumor localization procedures; clinical medical reagents; synthetic peptides for pharmaceutical use, namely, for cancer treatments, immunotherapy, cell therapy, antivirals and antibiotics; phytotherapy preparations for medical use; diagnostic preparations in vials for medical use; Drug delivery agents in the form of filled vials that facilitate the delivery of pharmaceutical preparations; pre-filled syringes for medical and clinical purposes, sold filled with indigo carmine solutions for marking tissue by injection application in surgery and internal medicine, for marking tissue of the digestive system by oral, anal or injectable, for the antiseptic treatment orally or topically, for marking and functional verification gynecological and urological systems, by instillation, injection or local application; all of these goods excluding food supplements, hand sanitizing preparations, insect repellents and bone growth media

Medical apparatus and instruments for use in exploratory endoscopy procedures in surgery, gynecology, urology, gastroenterology and medical imaging procedures; apparatus and instruments for diagnostic purposes for medical use for use in surgery, gynecology, urology and gastroenterology procedures

Filing History

REGISTERED-PRINCIPAL REGISTER
Aug 24, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 8, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jun 8, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 19, 2021 NONP
ELECTRONIC RECORD REVIEW COMPLETE
May 5, 2021 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Apr 30, 2021 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 27, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 27, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 27, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 27, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 27, 2021 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 22, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 22, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 22, 2021 TROA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 19, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 15, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 15, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 25, 2021 GNRN
NON-FINAL ACTION E-MAILED
Mar 25, 2021 GNRT
NON-FINAL ACTION WRITTEN
Mar 25, 2021 CNRT
ASSIGNED TO EXAMINER
Mar 24, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 17, 2020 NWOS
NEW APPLICATION ENTERED
Oct 30, 2020 NWAP